These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 24191281)

  • 1. Angiotensin-(1-7) modulates renal vascular resistance through inhibition of p38 mitogen-activated protein kinase in apolipoprotein E-deficient mice.
    Potthoff SA; Fähling M; Clasen T; Mende S; Ishak B; Suvorava T; Stamer S; Thieme M; Sivritas SH; Kojda G; Patzak A; Rump LC; Stegbauer J
    Hypertension; 2014 Feb; 63(2):265-72. PubMed ID: 24191281
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic treatment with angiotensin-(1-7) improves renal endothelial dysfunction in apolipoproteinE-deficient mice.
    Stegbauer J; Potthoff SA; Quack I; Mergia E; Clasen T; Friedrich S; Vonend O; Woznowski M; Königshausen E; Sellin L; Rump LC
    Br J Pharmacol; 2011 Jul; 163(5):974-83. PubMed ID: 21371005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiotensin-(1-7)-induced Mas receptor activation attenuates atherosclerosis through a nitric oxide-dependent mechanism in apolipoproteinE-KO mice.
    Yang G; Istas G; Höges S; Yakoub M; Hendgen-Cotta U; Rassaf T; Rodriguez-Mateos A; Hering L; Grandoch M; Mergia E; Rump LC; Stegbauer J
    Pflugers Arch; 2018 Apr; 470(4):661-667. PubMed ID: 29352340
    [TBL] [Abstract][Full Text] [Related]  

  • 4. AVE0991, a nonpeptide angiotensin-(1-7) mimic, inhibits angiotensin II-induced abdominal aortic aneurysm formation in apolipoprotein E knockout mice.
    Ma H; Wang YL; Hei NH; Li JL; Cao XR; Dong B; Yan WJ
    J Mol Med (Berl); 2020 Apr; 98(4):541-551. PubMed ID: 32060588
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiotensin-(1-7) regulates angiotensin II-induced matrix metalloproteinase-8 in vascular smooth muscle cells.
    Zhang F; Li S; Song J; Liu J; Cui Y; Chen H
    Atherosclerosis; 2017 Jun; 261():90-98. PubMed ID: 28283184
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vasoprotective and atheroprotective effects of angiotensin (1-7) in apolipoprotein E-deficient mice.
    Tesanovic S; Vinh A; Gaspari TA; Casley D; Widdop RE
    Arterioscler Thromb Vasc Biol; 2010 Aug; 30(8):1606-13. PubMed ID: 20448208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The influence of angiotensin-(1-7) Mas receptor agonist (AVE 0991) on mitochondrial proteome in kidneys of apoE knockout mice.
    Suski M; Olszanecki R; Stachowicz A; Madej J; Bujak-Giżycka B; Okoń K; Korbut R
    Biochim Biophys Acta; 2013 Dec; 1834(12):2463-9. PubMed ID: 23988828
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiotensin (1-7) prevents angiotensin II-induced nociceptive behaviour via inhibition of p38 MAPK phosphorylation mediated through spinal Mas receptors in mice.
    Nemoto W; Ogata Y; Nakagawasai O; Yaoita F; Tadano T; Tan-No K
    Eur J Pain; 2014 Nov; 18(10):1471-9. PubMed ID: 24733750
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiotensin-(1-7) inhibits angiotensin II-stimulated phosphorylation of MAP kinases in proximal tubular cells.
    Su Z; Zimpelmann J; Burns KD
    Kidney Int; 2006 Jun; 69(12):2212-8. PubMed ID: 16672906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An oral formulation of angiotensin-(1-7) reverses corpus cavernosum damages induced by hypercholesterolemia.
    Fraga-Silva RA; Costa-Fraga FP; Savergnini SQ; De Sousa FB; Montecucco F; da Silva D; Sinisterra RD; Mach F; Stergiopulos N; da Silva RF; Santos RA
    J Sex Med; 2013 Oct; 10(10):2430-42. PubMed ID: 23890028
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic p38 mitogen-activated protein kinase inhibition improves vascular function and remodeling in angiotensin II-dependent hypertension.
    Potthoff SA; Stamer S; Grave K; Königshausen E; Sivritas SH; Thieme M; Mori Y; Woznowski M; Rump LC; Stegbauer J
    J Renin Angiotensin Aldosterone Syst; 2016 Jul; 17(3):. PubMed ID: 27407119
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiotensin-(1-7) Attenuates Angiotensin II-Induced ICAM-1, VCAM-1, and MCP-1 Expression via the MAS Receptor Through Suppression of P38 and NF-κB Pathways in HUVECs.
    Liang B; Wang X; Zhang N; Yang H; Bai R; Liu M; Bian Y; Xiao C; Yang Z
    Cell Physiol Biochem; 2015; 35(6):2472-82. PubMed ID: 25967876
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mas receptor deficiency augments angiotensin II-induced atherosclerosis and aortic aneurysm ruptures in hypercholesterolemic male mice.
    Stegbauer J; Thatcher SE; Yang G; Bottermann K; Rump LC; Daugherty A; Cassis LA
    J Vasc Surg; 2019 Nov; 70(5):1658-1668.e1. PubMed ID: 30850299
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ang (1-7) protects islet endothelial cells from palmitate-induced apoptosis by AKT, eNOS, p38 MAPK, and JNK pathways.
    Yuan L; Lu CL; Wang Y; Li Y; Li XY
    J Diabetes Res; 2014; 2014():391476. PubMed ID: 24804268
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Ang-(1-7)/Mas-1 axis attenuates the expression and signalling of TGF-β1 induced by AngII in mouse skeletal muscle.
    Morales MG; Abrigo J; Meneses C; Simon F; Cisternas F; Rivera JC; Vazquez Y; Cabello-Verrugio C
    Clin Sci (Lond); 2014 Aug; 127(4):251-64. PubMed ID: 24588264
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-hypersensitive effect of angiotensin (1-7) on streptozotocin-induced diabetic neuropathic pain in mice.
    Ogata Y; Nemoto W; Yamagata R; Nakagawasai O; Shimoyama S; Furukawa T; Ueno S; Tan-No K
    Eur J Pain; 2019 Apr; 23(4):739-749. PubMed ID: 30421564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deletion of p47phox attenuates angiotensin II-induced abdominal aortic aneurysm formation in apolipoprotein E-deficient mice.
    Thomas M; Gavrila D; McCormick ML; Miller FJ; Daugherty A; Cassis LA; Dellsperger KC; Weintraub NL
    Circulation; 2006 Aug; 114(5):404-413. PubMed ID: 16864727
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiotensin II induces capillary formation from endothelial cells via the LOX-1 dependent redox-sensitive pathway.
    Hu C; Dandapat A; Mehta JL
    Hypertension; 2007 Nov; 50(5):952-7. PubMed ID: 17893372
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deletion of angiotensin-converting enzyme 2 exacerbates renal inflammation and injury in apolipoprotein E-deficient mice through modulation of the nephrin and TNF-alpha-TNFRSF1A signaling.
    Jin HY; Chen LJ; Zhang ZZ; Xu YL; Song B; Xu R; Oudit GY; Gao PJ; Zhu DL; Zhong JC
    J Transl Med; 2015 Aug; 13():255. PubMed ID: 26245758
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms of Mas1 Receptor-Mediated Signaling in the Vascular Endothelium.
    Hoffmann BR; Stodola TJ; Wagner JR; Didier DN; Exner EC; Lombard JH; Greene AS
    Arterioscler Thromb Vasc Biol; 2017 Mar; 37(3):433-445. PubMed ID: 28082260
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.